Indication
Cutaneous Leishmaniasis
6 clinical trials
9 products
Clinical trial
Documentation of Patient Outcomes for the Combination Treatment of Sodium Stibogluconate and Allopurinol in Complicated Cutaneous Leishmaniasis in EthiopiaStatus: Completed, Estimated PCD: 2022-12-15
Product
Sodium StibogluconateClinical trial
Treatment of Cutaneous Leishmaniasis With Liposomal Amphotericin B in the Elderly: a Randomized Clinical TrialStatus: Completed, Estimated PCD: 2021-09-01
Product
Liposomal amphotericin BClinical trial
Efficacy and Safety of Thermotherapy in Combination With Miltefosine Compared Iltefosine Monotherapy for the Treatment of New World Cutaneous Leishmaniasis: A Phase III, Open Label, Multicenter Randomized TrialStatus: Active (not recruiting), Estimated PCD: 2023-11-17
Product
Meglumine AntimoniateProduct
MiltefosineClinical trial
Tofacitinib Associated With Meglumine Antimoniate in the Control of American Tegumentary Leishmaniasis. A Randomized and Controlled Clinical Trial.Status: Not yet recruiting, Estimated PCD: 2024-10-01
Product
TofacitinibClinical trial
Association of Topical Sm29 in Gold Nanoparticles With Intravenous Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania Braziliensis: A Randomized Controlled Trial.Status: Completed, Estimated PCD: 2022-04-06
Product
Sm29 ProteinProduct
Pentavalent antimony (Sbv)Clinical trial
Spatial Analysis of Host-parasite Interactions in the Skin Across the Clinical Spectrum of Cutaneous Leishmaniasis in EthiopiaStatus: Active (not recruiting), Estimated PCD: 2024-03-30
Product
Venous Blood SampleProduct
Skin Slit